Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average.
Left:
||||
Revenue minus cost of goods sold
Latest
$483.50M
↑ 173% above average
Average (9y)
$177.11M
Historical baseline
Range
High:$483.50M
Low:$-183.07M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $483.50M | +24.3% |
| 2023 | $389.04M | +16.1% |
| 2022 | $335.01M | -0.1% |
| 2021 | $335.40M | +26.6% |
| 2020 | $264.90M | +179.7% |
| 2019 | $94.71M | +88.1% |
| 2018 | $50.35M | +1828.3% |
| 2017 | $2.61M | +101.4% |
| 2016 | $-183.07M | -13127.7% |
| 2015 | $-1.38M | - |